Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations

Bone

Volumn 16, Issue 6, 1995, Pages 657-662

  Schneider, G B ^a   Benis, K A ^a   Flay, N W ^a   Ireland, R A ^b   Popoff, S N ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone resorption; Macrophage; Macrophage activating factor; Osteoclast; Osteopetrosis; Vitamin D binding protein

Indexed keywords

MACROPHAGE ACTIVATING FACTOR; SUPEROXIDE; VITAMIN D BINDING PROTEIN;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; CELL COUNT; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; GENE MUTATION; MACROPHAGE ACTIVATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; RAT; SKELETON MALFORMATION; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

ANIMAL; BONE MARROW; BONE MARROW CELLS; BONE RESORPTION; DISEASE MODELS, ANIMAL; MACROPHAGE-ACTIVATING FACTORS; MICROSCOPY, ELECTRON; MUTATION; OSTEOCLASTS; OSTEOPETROSIS; OXIDATION-REDUCTION; RATS; SUPPORT, U.S. GOV'T, P.H.S.; TIBIA; VITAMIN D-BINDING PROTEIN;

EID: 0029080176     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(95)00118-W     Document Type: Article

References (37)

1. Neutrophil defect associated with malignant osteopetrosis
2. The effect of parathyroid hormone, 1,25Dihydroxycholecalciferol and prostaglandins on the cytoplasmic activity of isolated osteoclasts
3. Mineral metabolism in infants with malignant osteopetrosis: Heterogeneity in plasma 1,25-dihydroxyvitamin D levels and bone histology
4. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
5. An hereditary absence of the incisor teeth
6. Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats
7. Recombinant human interferon-γ therapy for osteopetrosis
8. Oxygen derived free radicals in osteoclasts:The specificity and location of the nitroblue tetrazolium reaction
9. Superoxide and bone resorption
10. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony stimulating factor
11. Marks, S. C., Jr. Pathogenesis of osteopetrosis of the ia rat: Reduced bone resorption due to reduced osteoclast function. Am J Anat 138: 165–190.
12. Osteopetrosis in the is rat cured by spleen cells from a normal littermate
13. Congenital osteopetrotic mutations as probes of the origin, structure and function of osteoclasts
14. The skeletal effects of colonystimulating factor-1 in toothless (osteopetrotic) rats: Persistent metaphysial sclerosis and the failure to restore subepiphyseal osteoclasts
15. Osteoclast biology in the osteopetrotic (op) rat
16. Transformations in osteoclast phenotype in is rats cured of congenital osteopetrosis
17. Administration of colony stimulating factor-1 corrects some macrophage, dental and skeletal defects in an osteopetrotic mutation (toothless fl) in the rat
18. The NBT slide test: A simple screening method for detecting chronic granulomatous disease and female carriers
19. Coexistence of reduced function of natural killer cells and osteoclasts in two distinct osteopetrotic mutations in the rat
20. Interdependence of skeletal sclerosis and elevated circulating levels of 1,25dihydroxyvitamin D in osteopetrotic (op and tl) rats
21. Conversion of the vitamin D binding protein to a macrophage activating factor: Associated defects in osteopetrotic mutations
22. Host defense in infantile osteopetrosis
23. Combination macrophage-colony stimulating factor and interferon-gamma administration ameliorates the osteopetrotic condition in microphthalmic (mi/mi) mice
24. An evaluation of the phagocytic cells in the is rat: Oxidative metabolism in monocytes and macrophages
25. Cellular specificity of the cure for osteopetrosis: Isolation of and treatment with pluripotent hemopoietic stem cells
26. Nature immunity and bone resorption
27. The diagnosis and cure of neonatal osteoporosis: Experimental evidence from congenitally osteopetrotic (ia) rats
28. Qualitative defects in natural killer cell function in is osteopetrotic rats
29. 3 on bone resorption and natural immunity in osteopetrotic (ia) rats
30. Defects in inflammationprimed macrophage activation in two osteopetrotic mutations [abstract]
31. Effects of 1,25-dihydroxyvitamin D infusions on serum and skeletal parameters in normal and osteopetrotic (op) rats [abstract]
32. Experimental studies of osteopetrosis in laboratory animals
33. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.
34. Vitamin D3 binding protein (group-specific component, Gc) is a precursor for the macrophage activating signal factor from lysophosphatidyl choline-treated lymphocytes
35. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells
36. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats
37. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene